We found in the previous section that HMGA1 is a regulon in the cluster 1 associated with poor prognosis in both the NB cohorts, regulated different genes in the MYCN immune signature and highly expressed in MNA NB patients (Figure S15A). This evidence concerns the gene HMGA1 and neuroblastoma.